Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 19 | 2023 | 844 | 1.750 |
Why?
|
| Cerebral Hemorrhage | 10 | 2022 | 108 | 1.170 |
Why?
|
| Deep Brain Stimulation | 6 | 2022 | 39 | 0.990 |
Why?
|
| Fragile X Syndrome | 5 | 2020 | 192 | 0.940 |
Why?
|
| Stroke | 6 | 2018 | 274 | 0.730 |
Why?
|
| Female | 56 | 2022 | 15704 | 0.730 |
Why?
|
| Male | 54 | 2022 | 15269 | 0.720 |
Why?
|
| Safety-net Providers | 1 | 2019 | 7 | 0.650 |
Why?
|
| Intracranial Aneurysm | 3 | 2014 | 38 | 0.650 |
Why?
|
| Hospitals, Public | 1 | 2019 | 25 | 0.640 |
Why?
|
| Humans | 67 | 2023 | 28395 | 0.640 |
Why?
|
| Sarcoidosis | 1 | 2019 | 14 | 0.630 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 18 | 0.630 |
Why?
|
| Aged | 40 | 2022 | 9256 | 0.610 |
Why?
|
| Middle Aged | 35 | 2022 | 9250 | 0.550 |
Why?
|
| Hallucinations | 3 | 2011 | 64 | 0.530 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 94 | 0.520 |
Why?
|
| Subthalamic Nucleus | 3 | 2022 | 19 | 0.510 |
Why?
|
| Thrombolytic Therapy | 3 | 2016 | 50 | 0.490 |
Why?
|
| Self-Help Groups | 1 | 2014 | 8 | 0.480 |
Why?
|
| Fibrinolytic Agents | 3 | 2011 | 59 | 0.480 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 15 | 0.470 |
Why?
|
| Ataxia | 3 | 2020 | 78 | 0.470 |
Why?
|
| Cholesterol | 1 | 2014 | 64 | 0.460 |
Why?
|
| Thrombectomy | 3 | 2021 | 31 | 0.460 |
Why?
|
| Tremor | 3 | 2020 | 117 | 0.460 |
Why?
|
| Social Media | 1 | 2014 | 50 | 0.440 |
Why?
|
| Retrospective Studies | 20 | 2021 | 3609 | 0.430 |
Why?
|
| Brain Ischemia | 3 | 2021 | 63 | 0.430 |
Why?
|
| Biostatistics | 1 | 2012 | 5 | 0.420 |
Why?
|
| Glucosylceramidase | 3 | 2022 | 17 | 0.410 |
Why?
|
| Adult | 21 | 2021 | 8097 | 0.410 |
Why?
|
| Bayes Theorem | 1 | 2012 | 43 | 0.410 |
Why?
|
| Heart Transplantation | 1 | 2012 | 30 | 0.410 |
Why?
|
| Health Facilities | 1 | 2011 | 22 | 0.380 |
Why?
|
| Hospital Mortality | 4 | 2017 | 147 | 0.380 |
Why?
|
| Risk Factors | 13 | 2021 | 2408 | 0.380 |
Why?
|
| Databases, Factual | 4 | 2022 | 358 | 0.380 |
Why?
|
| Hematoma, Subdural, Acute | 3 | 2017 | 7 | 0.370 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2016 | 39 | 0.360 |
Why?
|
| Young Adult | 10 | 2021 | 2069 | 0.350 |
Why?
|
| Length of Stay | 5 | 2018 | 328 | 0.350 |
Why?
|
| Severity of Illness Index | 9 | 2020 | 985 | 0.340 |
Why?
|
| Quality of Life | 5 | 2022 | 658 | 0.340 |
Why?
|
| Cognition Disorders | 4 | 2021 | 1003 | 0.330 |
Why?
|
| Parkinsonian Disorders | 3 | 2022 | 226 | 0.320 |
Why?
|
| Diet, Ketogenic | 2 | 2019 | 5 | 0.320 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2019 | 10 | 0.320 |
Why?
|
| Treatment Outcome | 15 | 2021 | 3615 | 0.310 |
Why?
|
| Disease Progression | 1 | 2011 | 717 | 0.310 |
Why?
|
| Brain | 5 | 2021 | 1663 | 0.290 |
Why?
|
| Gait | 3 | 2020 | 412 | 0.290 |
Why?
|
| Seizures | 2 | 2019 | 65 | 0.290 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 492 | 0.280 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 4851 | 0.270 |
Why?
|
| Postoperative Complications | 3 | 2018 | 931 | 0.270 |
Why?
|
| Neuropsychological Tests | 5 | 2022 | 1226 | 0.260 |
Why?
|
| Patient Transfer | 2 | 2017 | 23 | 0.260 |
Why?
|
| Illinois | 3 | 2019 | 246 | 0.260 |
Why?
|
| Mentors | 2 | 2023 | 43 | 0.260 |
Why?
|
| Caregivers | 3 | 2023 | 203 | 0.250 |
Why?
|
| Biopsy | 2 | 2019 | 220 | 0.250 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2020 | 46 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 1143 | 0.250 |
Why?
|
| Mutation | 3 | 2022 | 353 | 0.240 |
Why?
|
| Hospitalization | 3 | 2020 | 323 | 0.230 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2020 | 118 | 0.230 |
Why?
|
| Time Factors | 7 | 2020 | 1490 | 0.230 |
Why?
|
| Hematoma, Subdural | 2 | 2015 | 7 | 0.230 |
Why?
|
| Heterozygote | 2 | 2022 | 102 | 0.230 |
Why?
|
| Prognosis | 4 | 2020 | 825 | 0.220 |
Why?
|
| Attention | 3 | 2020 | 131 | 0.220 |
Why?
|
| Postural Balance | 2 | 2021 | 122 | 0.210 |
Why?
|
| Psychometrics | 2 | 2014 | 244 | 0.210 |
Why?
|
| Child, Preschool | 4 | 2021 | 689 | 0.210 |
Why?
|
| Walking Speed | 2 | 2020 | 40 | 0.200 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2011 | 42 | 0.200 |
Why?
|
| Homebound Persons | 1 | 2022 | 6 | 0.200 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2022 | 22 | 0.200 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2019 | 113 | 0.200 |
Why?
|
| Executive Function | 3 | 2018 | 115 | 0.200 |
Why?
|
| Lewy Body Disease | 1 | 2023 | 100 | 0.200 |
Why?
|
| Weather | 2 | 2019 | 13 | 0.200 |
Why?
|
| Mentoring | 1 | 2022 | 31 | 0.200 |
Why?
|
| Cognitive Dysfunction | 4 | 2020 | 1065 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 730 | 0.190 |
Why?
|
| Medical Futility | 1 | 2021 | 4 | 0.190 |
Why?
|
| Leukoaraiosis | 1 | 2021 | 7 | 0.190 |
Why?
|
| Longitudinal Studies | 6 | 2021 | 1384 | 0.190 |
Why?
|
| Multidetector Computed Tomography | 1 | 2021 | 11 | 0.190 |
Why?
|
| Prospective Studies | 8 | 2021 | 1804 | 0.180 |
Why?
|
| Adolescent | 8 | 2021 | 2307 | 0.180 |
Why?
|
| Cognition | 4 | 2022 | 1352 | 0.180 |
Why?
|
| Accidental Falls | 2 | 2020 | 113 | 0.180 |
Why?
|
| Martial Arts | 1 | 2020 | 4 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 32 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 181 | 0.180 |
Why?
|
| Sleep Wake Disorders | 2 | 2013 | 130 | 0.180 |
Why?
|
| Telemedicine | 1 | 2022 | 119 | 0.170 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2020 | 4 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2020 | 108 | 0.170 |
Why?
|
| Case-Control Studies | 7 | 2020 | 593 | 0.170 |
Why?
|
| Nootropic Agents | 1 | 2020 | 14 | 0.170 |
Why?
|
| Decompression, Surgical | 2 | 2018 | 129 | 0.170 |
Why?
|
| Odds Ratio | 4 | 2017 | 268 | 0.160 |
Why?
|
| Depression | 2 | 2016 | 452 | 0.160 |
Why?
|
| Arm | 1 | 2020 | 84 | 0.160 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 28 | 0.160 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 212 | 0.160 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2019 | 8 | 0.160 |
Why?
|
| Movement Disorders | 1 | 2020 | 90 | 0.160 |
Why?
|
| Child | 5 | 2022 | 1421 | 0.150 |
Why?
|
| Microelectrodes | 1 | 2018 | 18 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 21 | 0.150 |
Why?
|
| Middle Cerebral Artery | 1 | 2018 | 7 | 0.150 |
Why?
|
| Pilot Projects | 4 | 2023 | 439 | 0.150 |
Why?
|
| Population Surveillance | 1 | 2019 | 110 | 0.150 |
Why?
|
| Carotid Artery, Internal | 1 | 2018 | 8 | 0.150 |
Why?
|
| Walking | 1 | 2020 | 259 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 117 | 0.150 |
Why?
|
| Tertiary Care Centers | 2 | 2015 | 67 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2017 | 5 | 0.150 |
Why?
|
| Phenotype | 1 | 2019 | 310 | 0.150 |
Why?
|
| Lumbosacral Region | 1 | 2018 | 59 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2018 | 65 | 0.140 |
Why?
|
| Dopamine | 1 | 2018 | 87 | 0.140 |
Why?
|
| Cerebral Ventriculitis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Ventriculostomy | 1 | 2017 | 5 | 0.140 |
Why?
|
| Meningitis, Bacterial | 1 | 2017 | 4 | 0.140 |
Why?
|
| Meningitis, Aseptic | 1 | 2017 | 4 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2018 | 74 | 0.140 |
Why?
|
| Lactic Acid | 1 | 2017 | 10 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 11 | 0.140 |
Why?
|
| Disability Evaluation | 5 | 2021 | 289 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2018 | 118 | 0.140 |
Why?
|
| Fever | 1 | 2017 | 36 | 0.140 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 138 | 0.130 |
Why?
|
| Unemployment | 1 | 2016 | 2 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 121 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2018 | 1926 | 0.120 |
Why?
|
| Anxiety | 1 | 2016 | 161 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2015 | 47 | 0.120 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 41 | 0.120 |
Why?
|
| Spinal Fusion | 2 | 2018 | 464 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 4 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 114 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 384 | 0.110 |
Why?
|
| Neoplasms | 1 | 2016 | 239 | 0.110 |
Why?
|
| Cerebral Arteries | 1 | 2013 | 25 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 35 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 73 | 0.110 |
Why?
|
| Stochastic Processes | 1 | 2012 | 13 | 0.100 |
Why?
|
| Biomarkers | 3 | 2022 | 596 | 0.100 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2012 | 6 | 0.100 |
Why?
|
| House Calls | 2 | 2022 | 22 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2012 | 71 | 0.100 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2012 | 24 | 0.100 |
Why?
|
| Menopause, Premature | 1 | 2012 | 6 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2012 | 129 | 0.100 |
Why?
|
| Temporal Lobe | 1 | 2012 | 84 | 0.100 |
Why?
|
| Health Facility Size | 1 | 2011 | 3 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 31 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2013 | 134 | 0.100 |
Why?
|
| Drug Utilization | 1 | 2011 | 22 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 95 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 17 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2014 | 1215 | 0.090 |
Why?
|
| Certification | 1 | 2011 | 49 | 0.090 |
Why?
|
| Incidence | 3 | 2019 | 773 | 0.090 |
Why?
|
| Cholecystokinin | 1 | 2011 | 7 | 0.090 |
Why?
|
| Mental Status Schedule | 1 | 2011 | 93 | 0.090 |
Why?
|
| Logistic Models | 4 | 2017 | 395 | 0.090 |
Why?
|
| Communication Disorders | 1 | 2011 | 5 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 3 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 19 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2011 | 91 | 0.090 |
Why?
|
| Chicago | 3 | 2021 | 939 | 0.090 |
Why?
|
| Vitamin B Deficiency | 1 | 2010 | 1 | 0.090 |
Why?
|
| Medication Errors | 1 | 2010 | 15 | 0.090 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 6 | 0.090 |
Why?
|
| Reference Values | 2 | 2021 | 194 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 284 | 0.090 |
Why?
|
| Sleep | 1 | 2013 | 355 | 0.080 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 8 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 390 | 0.080 |
Why?
|
| Brain Infarction | 1 | 2009 | 75 | 0.080 |
Why?
|
| Radiography | 3 | 2015 | 639 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 517 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2017 | 676 | 0.070 |
Why?
|
| Age Factors | 3 | 2017 | 781 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 331 | 0.060 |
Why?
|
| Alleles | 2 | 2020 | 221 | 0.060 |
Why?
|
| Prevalence | 3 | 2013 | 467 | 0.060 |
Why?
|
| Range of Motion, Articular | 2 | 2020 | 704 | 0.060 |
Why?
|
| False Positive Reactions | 2 | 2017 | 36 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 146 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2018 | 300 | 0.050 |
Why?
|
| Comorbidity | 2 | 2017 | 500 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2023 | 35 | 0.050 |
Why?
|
| Hypertension | 2 | 2018 | 244 | 0.050 |
Why?
|
| Prebiotics | 1 | 2023 | 24 | 0.050 |
Why?
|
| Learning | 1 | 2023 | 73 | 0.050 |
Why?
|
| Genetic Testing | 2 | 2014 | 59 | 0.050 |
Why?
|
| Survivors | 2 | 2015 | 71 | 0.050 |
Why?
|
| Feces | 1 | 2023 | 108 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 1858 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 12 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 2118 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 93 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 44 | 0.050 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Walk Test | 1 | 2020 | 9 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 284 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 18 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 63 | 0.040 |
Why?
|
| Foot | 1 | 2020 | 44 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 231 | 0.040 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2019 | 3 | 0.040 |
Why?
|
| Neurosurgeons | 1 | 2018 | 7 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2018 | 21 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 66 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 44 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2018 | 59 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 47 | 0.040 |
Why?
|
| Independent Living | 1 | 2021 | 318 | 0.040 |
Why?
|
| United States | 2 | 2018 | 2196 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 645 | 0.040 |
Why?
|
| Putamen | 1 | 2018 | 20 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cameroon | 1 | 2017 | 1 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2017 | 11 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 145 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 32 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 58 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 122 | 0.040 |
Why?
|
| Motor Activity | 1 | 2020 | 329 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2017 | 25 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 43 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 128 | 0.030 |
Why?
|
| Heart Failure | 1 | 2018 | 179 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2017 | 57 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2017 | 80 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 188 | 0.030 |
Why?
|
| Educational Status | 1 | 2017 | 298 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 9 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 149 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 324 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 587 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 24 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 90 | 0.030 |
Why?
|
| Ventilator Weaning | 1 | 2015 | 37 | 0.030 |
Why?
|
| Language | 1 | 2014 | 71 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2013 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 31 | 0.030 |
Why?
|
| Troponin I | 1 | 2013 | 12 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2015 | 99 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2015 | 163 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2013 | 26 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2014 | 162 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 127 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2013 | 119 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 301 | 0.030 |
Why?
|
| HIV Infections | 1 | 2017 | 488 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 8 | 0.020 |
Why?
|
| Decision Trees | 1 | 2011 | 14 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 22 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 52 | 0.020 |
Why?
|
| Memory | 1 | 2013 | 302 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 134 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 63 | 0.020 |
Why?
|
| Social Behavior Disorders | 1 | 2011 | 5 | 0.020 |
Why?
|
| Language Disorders | 1 | 2011 | 7 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 85 | 0.020 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2010 | 2 | 0.020 |
Why?
|
| Drug Dosage Calculations | 1 | 2010 | 7 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2010 | 53 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 25 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 932 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 144 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 359 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 475 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 351 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 441 | 0.020 |
Why?
|